Back to results
US 2020/0368343 A1Published application
Zika virus mrna vaccines
AssigneeModernaTX, Inc.
InventorsGiuseppe Ciaramella, Eric Yi-Chun Huang, Kapil Bahl, Tal Zaks, Sunny Himansu
Life of this patent
Estimating the term…
Abstract
Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.
Claims26
A Zika virus (ZIKV) composition, comprising:
- a ribonucleic acid (RNA) polynucleotide having an open reading frame encoding at least one a ZIKV prME protein comprising an amino acid sequence having at least 90% identity to the amino acid sequence of SEQ ID NO:
- 97.
-28. (canceled)
-41. (canceled)
-44. (canceled)
-51. (canceled)
(canceled)
-477. (canceled)
Dependencies are inferred from the claim text.